PAG
CVS icon

Powers Advisory Group’s CVS Health CVS Stock Holding History

Powers Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,448
Closed -$217K – 104
2024
Q3 		$217K Sell
3,448
-790
-19% -$46.1K 0.11% 96
2024
Q2 		$250K Buy
4,238
+98
+2% +$6.13K 0.14% 87
2024
Q1 		$330K Buy
4,140
+7
+0.2% +$535 0.19% 76
2023
Q4 		$326K Buy
4,133
+91
+2% +$6.48K 0.2% 74
2023
Q3 		$282K Buy
4,042
+23
+0.6% +$1.63K 0.19% 76
2023
Q2 		$278K Buy
4,019
+218
+6% +$15.5K 0.18% 79
2023
Q1 		$282K Buy
3,801
+20
+0.5% +$1.68K 0.2% 75
2022
Q4 		$352K Buy
3,781
+16
+0.4% +$1.54K 0.26% 71
2022
Q3 		$359K Sell
3,765
-53
-1% -$5.25K 0.29% 68
2022
Q2 		$354K Buy
3,818
+17
+0.4% +$1.66K 0.27% 72
2022
Q1 		$385K Buy
3,801
+14
+0.4% +$1.47K 0.27% 73
2021
Q4 		$391K Buy
+3,787
New +$350K 0.28% 71

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Powers Advisory Group's CVS Position: Q4 2024 in Review

Powers Advisory Group sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,448 shares — an estimated $217K sold.

Powers Advisory Group first reported a position in CVS in Q4 2021 and held it in 12 quarters. The position peaked at $391K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Powers Advisory Group reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Powers Advisory Group sold 3,448 CVS Health shares in Q4 2024, an estimated $217K.
  • Powers Advisory Group first reported a position in CVS Health in Q4 2021 and held it in 12 quarters.
  • Powers Advisory Group's CVS Health position peaked at $391K in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Powers Advisory Group's 13F filing for Q4 2024, filed 23 Jan 2025.